TherapeuticsMD, Inc. (29TA.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 10:04AM CEST
| Previous close | 1.8400 |
| Open | 1.8300 |
| Bid | 1.8300 x N/A |
| Ask | 1.9100 x N/A |
| Day's range | 1.8300 - 1.8300 |
| 52-week range | 1.6700 - 4.0800 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 21.667M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
TherapeuticsMD Announces First Quarter 2024 Financial Results
BOCA RATON, Fla., May 10, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024.
- Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.
- Business Wire
TherapeuticsMD Announces Third Quarter 2023 Financial Results
BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.
© 2024 Yahoo. All rights reserved.